Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ILution travoprost by Glaukos for Open-Angle Glaucoma: Likelihood of Approval
ILution travoprost is under clinical development by Glaukos and currently in Phase II for Open-Angle Glaucoma. According to GlobalData, Phase...
ILution travoprost by Glaukos for Ocular Hypertension: Likelihood of Approval
ILution travoprost is under clinical development by Glaukos and currently in Phase II for Ocular Hypertension. According to GlobalData, Phase...
ILution travoprost by Glaukos for Open-Angle Glaucoma: Likelihood of Approval
ILution travoprost is under clinical development by Glaukos and currently in Phase II for Open-Angle Glaucoma. According to GlobalData, Phase...
ILution travoprost by Glaukos for Ocular Hypertension: Likelihood of Approval
ILution travoprost is under clinical development by Glaukos and currently in Phase II for Ocular Hypertension. According to GlobalData, Phase...
Pilocarpine by Glaukos for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Pilocarpine is under clinical development by Glaukos and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to GlobalData,...
GLK-302 by Glaukos for Presbyopia: Likelihood of Approval
GLK-302 is under clinical development by Glaukos and currently in Phase II for Presbyopia. According to GlobalData, Phase II drugs...
IVMED-80 by Glaukos for Keratoconus: Likelihood of Approval
IVMED-80 is under clinical development by Glaukos and currently in Phase III for Keratoconus. According to GlobalData, Phase III drugs...